Our Pricing

Wegovy Maintenance Dose: Long-Term Weight Management in the UK

Published on: June 03, 2026

Reaching your goal weight with Wegovy is a significant achievement, but maintaining that weight loss requires a strategic approach to your wegovy maintenance dose uk online prescription. At Cured Pharmacy, our UK-registered clinical team provides ongoing support and transparent pricing from £79.00 for patients transitioning to long-term maintenance therapy with semaglutide injections.

Understanding Wegovy Maintenance Dosing After Weight Loss

Once you've achieved your target weight with Wegovy (semaglutide 2.4mg), the question isn't whether to continue treatment, but how to optimise your maintenance dose. Clinical evidence from the STEP 1 extension study demonstrates that patients who discontinued semaglutide regained approximately two-thirds of their lost weight within one year, whilst those who continued maintenance therapy sustained their weight loss [1].

The standard maintenance dose for Wegovy is 2.4mg once weekly, which is the same as the maximum escalation dose used during the initial weight loss phase [2]. However, some UK prescribers may adjust this based on individual response, tolerability, and weight stability. Your maintenance strategy should be personalised following assessment by a qualified healthcare professional.

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team work with patients to ensure seamless transition from active weight loss to long-term maintenance, with transparent pricing of £79.00 per month and discreet home delivery across the UK.

Clinical Evidence for Long-Term Wegovy Maintenance

The STEP 4 trial specifically examined maintenance therapy in patients who had already lost weight on semaglutide. Participants who continued treatment maintained an average 17.4% total body weight loss at 68 weeks, compared to just 5.6% in those switched to placebo — a statistically significant difference demonstrating the importance of ongoing therapy [3].

Long-term data from the STEP 5 trial followed patients for 104 weeks (two years), with participants maintaining an average 15.2% body weight reduction on the 2.4mg maintenance dose [4]. These findings support the MHRA's licensing of Wegovy for chronic weight management rather than short-term intervention.

What Happens If You Stop Wegovy After Reaching Your Goal?

Obesity is recognised by NICE and the MHRA as a chronic relapsing condition, not simply a lifestyle choice. When GLP-1 receptor agonist therapy is discontinued, the physiological changes that supported weight loss — including reduced appetite, improved satiety signalling, and enhanced insulin sensitivity — gradually reverse [1][3].

Most patients experience weight regain within 12 months of stopping treatment, which is why UK clinical guidelines increasingly recommend ongoing maintenance therapy for eligible patients, subject to regular review by a prescriber.

Wegovy Maintenance Dose Adjustments and Personalisation

Whilst 2.4mg weekly remains the licensed maintenance dose, some patients may find that a lower dose effectively maintains their weight loss with improved tolerability. The STEP 8 trial compared semaglutide 2.4mg with 1.0mg, finding superior weight maintenance with the higher dose, though both groups maintained clinically significant weight loss [2].

Dose adjustments should only be made under guidance from your UK prescriber, who will consider factors including your weight stability over the preceding three months, side effect profile, concurrent medications, and overall metabolic health markers. Never adjust your Wegovy dose independently.

When to Consider Dose Reduction

Your prescriber may discuss a lower maintenance dose if you experience persistent gastrointestinal side effects (nausea, vomiting, diarrhoea) that affect quality of life, have maintained stable weight for six months or longer at a lower dose, or develop medical conditions that alter your risk-benefit profile. Any changes require clinical assessment and monitoring.

Combining Wegovy Maintenance with Lifestyle Modifications

Semaglutide maintenance therapy works most effectively when combined with sustained dietary and physical activity modifications. The STEP trials all included lifestyle intervention components alongside medication, reflecting real-world best practice for chronic weight management [1][4].

UK clinical guidance recommends that patients on long-term GLP-1 therapy maintain a reduced-calorie diet (typically 500-1000 kcal daily deficit from maintenance requirements) and engage in at least 150 minutes of moderate-intensity physical activity weekly. These behavioural strategies complement the pharmacological effects of Wegovy.

At Cured Pharmacy, we provide educational resources alongside your prescription to support long-term success. Our clinical team can signpost you to evidence-based nutrition and exercise guidance appropriate for maintenance-phase weight management.

Cost and Accessibility of Wegovy Maintenance in the UK

Long-term maintenance therapy requires consideration of both clinical effectiveness and financial sustainability. Cured Pharmacy offers transparent upfront pricing at £79.00 for Wegovy, with no hidden consultation fees or subscription charges. Prices are confirmed before you complete your free online assessment with a UK prescriber.

NHS prescription of Wegovy for weight maintenance remains limited in most UK regions due to funding constraints, meaning many patients access treatment through registered online pharmacies. All Wegovy supplied by Cured Pharmacy is UK-licensed medication dispensed following clinical assessment by GPhC-registered prescribers.

Our discreet packaging and next-day delivery options ensure continuity of treatment without disruption to your maintenance schedule. Automatic refill reminders help prevent missed doses, which is particularly important for maintaining stable therapeutic semaglutide levels.

Wegovy Maintenance vs Alternative Weight Loss Treatments

Patients sometimes ask whether they can switch to a different weight management medication for maintenance. Alternatives include other GLP-1 receptor agonists or dual GIP/GLP-1 agonists, each with distinct efficacy and tolerability profiles. Your UK prescriber can discuss whether switching treatments might be appropriate based on your individual response and clinical goals.

How to Order Wegovy Maintenance Dose Online from Cured Pharmacy

Ordering your wegovy maintenance dose uk online from Cured Pharmacy takes under three minutes. Complete our confidential medical questionnaire, which covers your weight loss history, current health status, medications, and treatment goals. A UK-registered prescriber reviews your assessment, typically within 24 hours on working days.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy (9012511), where our team dispenses genuine UK-licensed Wegovy pens. We offer discreet next-day delivery across the UK, with all packaging unmarked for complete privacy.

Ongoing prescriptions for maintenance therapy require periodic clinical review to ensure continued safety and appropriateness. Our prescribers will contact you every three to six months to assess your progress, discuss any side effects, and confirm that Wegovy remains the right treatment for your long-term weight management.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Davies, M., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
4. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.